These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12908351)

  • 41. Clinical and biological consequences of immunization to infliximab in pediatric Crohn's disease.
    Candon S; Mosca A; Ruemmele F; Goulet O; Chatenoud L; Cézard JP
    Clin Immunol; 2006 Jan; 118(1):11-9. PubMed ID: 16125467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severe adenovirus pneumonia (AVP) following infliximab infusion for the treatment of Crohn's disease.
    Ahmad NM; Ahmad KM; Younus F
    J Infect; 2007 Jan; 54(1):e29-32. PubMed ID: 16678268
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
    Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C
    Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumour necrosis factor alpha antibody affects gastrin release in Crohn disease.
    Hopman WP; de Jong DJ; Naber AH; Jansen JB
    Scand J Gastroenterol; 2003 May; 38(5):522-5. PubMed ID: 12795463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psoriasis and psoriatic arthritis induced in a patient treated with infliximab for Crohn's disease.
    Tichy M; Tichy M; Kopova R; Sternbersky J; Ditrichova D
    J Dermatolog Treat; 2012 Jun; 23(3):208-11. PubMed ID: 21254868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pericarditis as a complication of infliximab therapy in Crohn's disease.
    Burke JP; Kelleher B; Ramadan S; Quinlan M; Sugrue D; O'Donovan MA
    Inflamm Bowel Dis; 2008 Mar; 14(3):428-9. PubMed ID: 17924565
    [No Abstract]   [Full Text] [Related]  

  • 47. Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for).
    Shanahan F
    Inflamm Bowel Dis; 2000 May; 6(2):137-9. PubMed ID: 10833074
    [No Abstract]   [Full Text] [Related]  

  • 48. Listeria infection in patients on anti-TNF treatment: report of two cases and review of the literature.
    Abreu C; Magro F; Vilas-Boas F; Lopes S; Macedo G; Sarmento A
    J Crohns Colitis; 2013 Mar; 7(2):175-82. PubMed ID: 22626505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pulmonary actinomycosis complicating infliximab therapy for Crohn's disease.
    Cohen RD; Bowie WR; Enns R; Flint J; Fitzgerald JM
    Thorax; 2007 Nov; 62(11):1013-4. PubMed ID: 17965080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of patients with Crohn's disease and concomitant chronic hepatitis C with a chimeric monoclonal antibody to TNF.
    Holtmann MH; Galle PR; Neurath MF
    Am J Gastroenterol; 2003 Feb; 98(2):504-5. PubMed ID: 12591081
    [No Abstract]   [Full Text] [Related]  

  • 51. Induction of manic switch by the tumour necrosis factor-alpha antagonist infliximab.
    Elisa B; Beny L
    Psychiatry Clin Neurosci; 2010 Aug; 64(4):442-3. PubMed ID: 20653912
    [No Abstract]   [Full Text] [Related]  

  • 52. [Disseminated tuberculosis following infliximab therapy for Crohn disease: a case report].
    Bouchentouf R; Yasser Z; Aitbenasser MA
    Rev Pneumol Clin; 2014 Dec; 70(6):366-9. PubMed ID: 25131370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amicrobial pustulosis-like rash in a patient with Crohn's disease under anti-TNF-alpha blocker.
    Lee HY; Pelivani N; Beltraminelli H; Hegyi I; Yawalkar N; Borradori L
    Dermatology; 2011; 222(4):304-10. PubMed ID: 21757882
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infliximab treatment for Crohn's disease.
    Conroy CA; Cattell R
    Postgrad Med J; 2001 Jul; 77(909):436-40. PubMed ID: 11423591
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasmablastic lymphoma presenting as a paravertebral mass in a patient with Crohn's disease after immunosuppressive therapy.
    Redmond M; Quinn J; Murphy P; Patchett S; Leader M
    J Clin Pathol; 2007 Jan; 60(1):80-1. PubMed ID: 17213349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reactivation tuberculosis in a patient with anti-TNF-alpha treatment.
    Núñez Martínez O; Ripoll Noiseux C; Carneros Martín JA; González Lara V; Gregorio Marañón HG
    Am J Gastroenterol; 2001 May; 96(5):1665-6. PubMed ID: 11374737
    [No Abstract]   [Full Text] [Related]  

  • 57. Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
    Seddik M; Melliez H; Seguy D; Viget N; Cortot A; Colombel JF
    Inflamm Bowel Dis; 2005 Jun; 11(6):618-20. PubMed ID: 15905713
    [No Abstract]   [Full Text] [Related]  

  • 58. [Psoriasis induced by infliximab].
    Fernandes IC; Torres T; Sanches M; Velho G; Lago P; Selores M
    Acta Med Port; 2011 Dec; 24 Suppl 3():709-12. PubMed ID: 22856418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease.
    Bell S; Kamm MA
    Lancet; 2000 Mar; 355(9207):858-60. PubMed ID: 10752696
    [No Abstract]   [Full Text] [Related]  

  • 60. Invasive pulmonary aspergillosis associated with infliximab therapy.
    Warris A; Bjørneklett A; Gaustad P
    N Engl J Med; 2001 Apr; 344(14):1099-100. PubMed ID: 11291675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.